Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 6494795, 6 pages
https://doi.org/10.1155/2017/6494795
Review Article

Role of T Lymphocytes in Type 2 Diabetes and Diabetes-Associated Inflammation

1College of Health Science & Nursing, Wuhan Polytechnic University, Wuhan, Hubei, China
2Cardiovascular Research Institute, Case Western Reserve University, Cleveland, OH, USA

Correspondence should be addressed to Jixin Zhong; moc.361@026nixijgnohz

Received 23 July 2016; Revised 30 December 2016; Accepted 12 January 2017; Published 31 January 2017

Academic Editor: Monica Bullo

Copyright © 2017 Chang Xia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Guzmán-Flores and S. López-Briones, “Cells of the innate and adaptive immunity in type 2 diabetes mellitus and obesity,” Gaceta Medica de Mexico, vol. 148, no. 4, pp. 381–389, 2012. View at Google Scholar · View at Scopus
  2. C. J. Shu, C. Benoist, and D. Mathis, “The immune system's involvement in obesity-driven type 2 diabetes,” Seminars in Immunology, vol. 24, no. 6, pp. 436–442, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Guarner and M. E. Rubio-Ruiz, “Low-grade systemic inflammation connects aging, metabolic syndrome and cardiovascular disease,” Aging and Health—A Systems Biology Perspective, vol. 40, pp. 99–106, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. G. S. Hotamisligil, N. S. Shargill, and B. M. Spiegelman, “Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance,” Science, vol. 259, no. 5091, pp. 87–91, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Mathis, “Immunological goings-on in visceral adipose tissue,” Cell Metabolism, vol. 17, no. 6, pp. 851–859, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Ouchi, J. L. Parker, J. J. Lugus, and K. Walsh, “Adipokines in inflammation and metabolic disease,” Nature Reviews Immunology, vol. 11, no. 2, pp. 85–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. I. Odegaard, R. R. Ricardo-Gonzalez, M. H. Goforth et al., “Macrophage-specific PPARγ controls alternative activation and improves insulin resistance,” Nature, vol. 447, no. 7148, pp. 1116–1120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr., “Obesity is associated with macrophage accumulation in adipose tissue,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796–1808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Boutens and R. Stienstra, “Adipose tissue macrophages: going off track during obesity,” Diabetologia, vol. 59, no. 5, pp. 879–894, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Shirakawa, X. Yan, K. Shinmura et al., “Obesity accelerates T cell senescence in murine visceral adipose tissue,” Journal of Clinical Investigation, vol. 126, no. 12, pp. 4626–4639, 2016. View at Publisher · View at Google Scholar
  11. T. Deng, C. J. Lyon, L. J. Minze et al., “Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation,” Cell Metabolism, vol. 17, no. 3, pp. 411–422, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Raphael, S. Nalawade, T. N. Eagar, and T. G. Forsthuber, “T cell subsets and their signature cytokines in autoimmune and inflammatory diseases,” Cytokine, vol. 74, no. 1, pp. 5–17, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. S. E. Kahn, R. L. Hull, and K. M. Utzschneider, “Mechanisms linking obesity to insulin resistance and type 2 diabetes,” Nature, vol. 444, no. 7121, pp. 840–846, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. F. O. Martinez, “Macrophage activation and polarization,” Frontiers in Bioscience, vol. 13, no. 13, p. 453, 2008. View at Publisher · View at Google Scholar
  15. D. E. Cintra, J. R. Pauli, E. P. Araújo et al., “Interleukin-10 is a protective factor against diet-induced insulin resistance in liver,” Journal of Hepatology, vol. 48, no. 4, pp. 628–637, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. C. N. Lumeng, J. L. Bodzin, and A. R. Saltiel, “Obesity induces a phenotypic switch in adipose tissue macrophage polarization,” Journal of Clinical Investigation, vol. 117, no. 1, pp. 175–184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Winer, Y. Chan, G. Paltser et al., “Normalization of obesity-associated insulin resistance through immunotherapy,” Nature Medicine, vol. 15, no. 8, pp. 921–929, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. F. C. McGillicuddy, E. H. Chiquoine, C. C. Hinkle et al., “Interferon γ attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway,” The Journal of Biological Chemistry, vol. 284, no. 46, pp. 31936–31944, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Feuerer, L. Herrero, D. Cipolletta et al., “Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters,” Nature Medicine, vol. 15, no. 8, pp. 930–939, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Chatzigeorgiou, K. P. Karalis, S. R. Bornstein, and T. Chavakis, “Lymphocytes in obesity-related adipose tissue inflammation,” Diabetologia, vol. 55, no. 10, pp. 2583–2592, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Nishimura, I. Manabe, M. Nagasaki et al., “CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity,” Nature Medicine, vol. 15, no. 8, pp. 914–920, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. T. McLaughlin, L. Liu, C. Lamendola et al., “T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 12, pp. 2637–2643, 2014. View at Publisher · View at Google Scholar
  23. C. Zeng, X. Shi, B. Zhang et al., “The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications,” Journal of Molecular Medicine, vol. 90, no. 2, pp. 175–186, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. P. Nekoua, R. Fachinan, A. K. Atchamou et al., “Modulation of immune cells and Th1/Th2 cytokines in insulin-treated type 2 diabetes mellitus,” African Health Sciences, vol. 16, no. 3, pp. 712–724, 2016. View at Publisher · View at Google Scholar
  25. Y. S. Lee, P. Li, J. Y. Huh et al., “Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance,” Diabetes, vol. 60, no. 10, pp. 2474–2483, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. K. A. Harford, C. M. Reynolds, F. C. McGillicuddy, and H. M. Roche, “Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue,” Proceedings of the Nutrition Society, vol. 70, no. 4, pp. 408–417, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. F. Navarro and C. Mora, “Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy,” TheScientificWorldJournal, vol. 6, pp. 908–917, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Abouzeid and N. Sherif, “Role of alteration in Treg/Th17 cells’ balance in nephropathic patients with Type 2 diabetes mellitus,” Electronic physician, vol. 7, no. 8, pp. 1613–1618, 2015. View at Publisher · View at Google Scholar
  29. D. Wu, A. B. Molofsky, H.-E. Liang et al., “Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis,” Science, vol. 332, no. 6026, pp. 243–247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Francisco, A. Catai, S. Moura-Tonello et al., “Cytokine profile and lymphocyte subsets in type 2 diabetes,” Brazilian Journal of Medical and Biological Research, vol. 49, no. 4, 2016. View at Publisher · View at Google Scholar
  31. S. Mocellin, F. Marincola, C. R. Rossi, D. Nitti, and M. Lise, “The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle,” Cytokine and Growth Factor Reviews, vol. 15, no. 1, pp. 61–76, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Ilan, R. Maron, A.-M. Tukpah et al., “Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 21, pp. 9765–9770, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Zhang, C. Xiao, P. Wang et al., “The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: relationship with diabetic nephropathy,” Human Immunology, vol. 75, no. 4, pp. 289–296, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. L. A. Zuniga, W. Shen, B. Joyce-Shaikh et al., “IL-17 regulates adipogenesis, glucose homeostasis, and obesity,” The Journal of Immunology, vol. 185, no. 11, pp. 6947–6959, 2010. View at Publisher · View at Google Scholar
  35. L. Garidou, C. Pomié, P. Klopp et al., “The gut microbiota regulates intestinal CD4 T cells expressing RORγt and controls metabolic disease,” Cell Metabolism, vol. 22, no. 1, pp. 100–112, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. M. K. Hamilton, G. Boudry, D. G. Lemay, and H. E. Raybould, “Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 308, no. 10, pp. G840–G851, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Bertola, T. Ciucci, D. Rousseau et al., “Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients,” Diabetes, vol. 61, no. 9, pp. 2238–2247, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. B.-C. Lee and J. Lee, “Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1842, no. 3, pp. 446–462, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Dalmas, N. Venteclef, C. Caer et al., “T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes,” Diabetes, vol. 63, no. 6, pp. 1966–1977, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Zhao, D. Tang, S. Yi et al., “Elevated peripheral frequencies of Th22 cells: a novel potent participant in obesity and type 2 diabetes,” PLoS ONE, vol. 9, no. 1, Article ID e85770, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. B. C. Ip, A. E. Hogan, and B. S. Nikolajczyk, “Lymphocyte roles in metabolic dysfunction: of men and mice,” Trends in Endocrinology and Metabolism, vol. 26, no. 2, pp. 91–100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Zheng and A. Y. Rudensky, “Foxp3 in control of the regulatory T cell lineage,” Nature Immunology, vol. 8, no. 5, pp. 457–462, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono, “Regulatory T cells and immune tolerance,” Cell, vol. 133, no. 5, pp. 775–787, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. T. J. Murphy, N. N. Choileain, Y. Zang, J. A. Mannick, and J. A. Lederer, “CD4+CD25+ regulatory T cells control innate immune reactivity after injury,” Journal of Immunology, vol. 174, no. 5, pp. 2957–2963, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. L. T. Nguyen, J. Jacobs, D. Mathis, and C. Benoist, “Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis,” Arthritis & Rheumatism, vol. 56, no. 2, pp. 509–520, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Jagannathan-Bogdan, M. E. McDonnell, H. Shin et al., “Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes,” Journal of Immunology, vol. 186, no. 2, pp. 1162–1172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. J. M. Guzmán-Flores and D. P. Portales-Pérez, “Mechanisms of suppression by regulatory T cells (Treg),” Gaceta Medica de Mexico, vol. 149, no. 6, pp. 630–638, 2013. View at Google Scholar · View at Scopus
  48. M. F. Gregor and G. S. Hotamisligil, “Inflammatory mechanisms in obesity,” Annual Review of Immunology, vol. 29, pp. 415–445, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Zeng, H. Lu, H. Deng, P. Mu, X. Li, and M. Wang, “Noninferiority effects on glycemic control and β-cell function improvement in newly diagnosed type 2 diabetes patients: basal insulin monotherapy versus continuous subcutaneous insulin infusion treatment,” Diabetes Technology and Therapeutics, vol. 14, no. 1, pp. 35–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. V. Della Latta, M. Cabiati, S. Rocchiccioli, S. Del Ry, and M.-A. Morales, “The role of the adenosinergic system in lung fibrosis,” Pharmacological Research, vol. 76, pp. 182–189, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Gu, X. Ni, X. Pan et al., “Human CD39hi regulatory T cells present stronger stability and function under inflammatory conditions,” Cellular & Molecular Immunology, vol. 13, pp. 1–8, 2016. View at Publisher · View at Google Scholar
  52. Y. Sun, W.-Z. Liu, T. Liu, X. Feng, N. Yang, and H.-F. Zhou, “Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis,” Journal of Receptors and Signal Transduction, vol. 35, no. 6, pp. 600–604, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. U. Kintscher, M. Hartge, K. Hess et al., “T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 7, pp. 1304–1310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Luck, S. Tsai, J. Chung et al., “Regulation of obesity-related insulin resistance with gut anti-inflammatory agents,” Cell Metabolism, vol. 21, no. 4, pp. 527–542, 2015. View at Publisher · View at Google Scholar
  55. D. S. Vinay and B. S. Kwon, “Role of 4-1BB in immune responses,” Seminars in Immunology, vol. 10, no. 6, pp. 481–489, 1998. View at Publisher · View at Google Scholar · View at Scopus
  56. T. H. Tu, C.-S. Kim, J.-H. Kang et al., “Levels of 4-1BB transcripts and soluble 4-1BB protein are elevated in the adipose tissue of human obese subjects and are associated with inflammatory and metabolic parameters,” International Journal of Obesity, vol. 38, no. 8, pp. 1075–1082, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. T. H. Tu, C.-S. Kim, T. Goto, T. Kawada, B.-S. Kim, and R. Yu, “4-1BB/4-1BBL interaction promotes obesity-induced adipose inflammation by triggering bidirectional inflammatory signaling in adipocytes/macrophages,” Mediators of Inflammation, vol. 2012, Article ID 972629, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. C. S. Kim, J. G. Kim, B. J. Lee et al., “Deficiency for costimulatory receptor 4-1BB protects against obesity-induced inflammation and metabolic disorders,” Diabetes, vol. 60, no. 12, pp. 3159–3168, 2011. View at Google Scholar
  59. K. A. Rhodes, E. M. Andrew, D. J. Newton, D. Tramonti, and S. R. Carding, “A subset of IL-10-producing γδ T cells protect the liver from Listeria-elicited, CD8+ T cell-mediated injury,” European Journal of Immunology, vol. 38, no. 8, pp. 2274–2283, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. K. D. C. Jensen, X. Su, S. Shin et al., “Thymic selection determines γδ T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon γ,” Immunity, vol. 29, no. 1, pp. 90–100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. D. E. Lackey and J. M. Olefsky, “Regulation of metabolism by the innate immune system,” Nature Reviews Endocrinology, vol. 12, no. 1, pp. 15–20, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Dimova, M. Brouwer, F. Gosselin et al., “Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire,” Proceedings of the National Academy of Sciences, vol. 112, no. 6, pp. E556–E565, 2015. View at Publisher · View at Google Scholar
  63. A. E. Costanzo, K. R. Taylor, S. Dutt, P. P. Han, K. Fujioka, and J. M. Jameson, “Obesity impairs γδ T cell homeostasis and antiviral function in humans,” PLoS ONE, vol. 10, no. 3, Article ID e0120918, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. L. A. Lynch, J. M. O'Connell, A. K. Kwasnik, T. J. Cawood, C. O'Farrelly, and D. B. O'Shea, “Are natural killer cells protecting the metabolically healthy obese patient?” Obesity, vol. 17, no. 3, pp. 601–605, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Lynch, D. O'Shea, D. C. Winter, J. Geoghegan, D. G. Doherty, and C. O'Farrelly, “Invariant NKT cells and CD1d+ cells amass in human omentum and are depleted in patients with cancer and obesity,” European Journal of Immunology, vol. 39, no. 7, pp. 1893–1901, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. L. Lynch, M. Nowak, B. Varghese et al., “Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production,” Immunity, vol. 37, no. 3, pp. 574–587, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Brigl and M. B. Brenner, “CD1: antigen presentation and T cell function,” Annual Review of Immunology, vol. 22, pp. 817–890, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. E. M. Beckman, S. A. Porcelli, C. T. Morita, S. M. Behar, S. T. Furlong, and M. B. Brenner, “Recognition of a lipid antigen by GDI-restricted αβ+ T cells,” Nature, vol. 372, no. 6507, pp. 691–694, 1994. View at Publisher · View at Google Scholar · View at Scopus
  69. L. Lynch, X. Michelet, S. Zhang et al., “Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of Treg cells and macrophages in adipose tissue,” Nature Immunology, vol. 16, no. 1, pp. 85–95, 2015. View at Publisher · View at Google Scholar · View at Scopus
  70. H. S. Schipper, M. Rakhshandehroo, S. F. J. Van De Graaf et al., “Natural killer T cells in adipose tissue prevent insulin resistance,” Journal of Clinical Investigation, vol. 122, no. 9, pp. 3343–3354, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Y. Huh, J. I. Kim, Y. J. Park et al., “A novel function of adipocytes in lipid antigen presentation to iNKT cells,” Molecular and Cellular Biology, vol. 33, no. 2, pp. 328–339, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. E. Hams, R. M. Locksley, A. N. J. McKenzie, and P. G. Fallon, “Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice,” The Journal of Immunology, vol. 191, no. 11, pp. 5349–5353, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. Y. Ji, S. Sun, A. Xu et al., “Activation of natural killer T cells promotes M2 macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity,” Journal of Biological Chemistry, vol. 287, no. 17, pp. 13561–13571, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Kohlgruber and L. Lynch, “Adipose tissue inflammation in the pathogenesis of type 2 diabetes,” Current Diabetes Reports, vol. 15, no. 11, article no. 92, 2015. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Tsai, X. Clemente-Casares, X. S. Revelo, S. Winer, and D. A. Winer, “Are obesity-related insulin resistance and type 2 diabetes autoimmune diseases?” Diabetes, vol. 64, no. 6, pp. 1886–1897, 2015. View at Publisher · View at Google Scholar · View at Scopus